Meta-Analysis of HER2-Enriched Subtype Predicting the Pathological Complete Response Within HER2-Positive Breast Cancer in Patients Who Received Neoadjuvant Treatment

BACKGROUND: This meta-analysis aimed to better elucidate the predictive value of human epidermal growth factor receptor 2 (HER2)-enriched subtype of pathological complete response (pCR) rate within HER2-positive breast cancer patients receiving neoadjuvant treatment. METHODS: We identified prospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Guoshuang, Zhao, Fuxing, Huo, Xingfa, Ren, Dengfeng, Du, Feng, Zheng, Fangchao, Zhao, Jiuda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343531/
https://www.ncbi.nlm.nih.gov/pubmed/34367947
http://dx.doi.org/10.3389/fonc.2021.632357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343531/
https://www.ncbi.nlm.nih.gov/pubmed/34367947
http://dx.doi.org/10.3389/fonc.2021.632357

Ejemplares similares